Table 2.
5-ALA-SFC n = 35 |
Placebo n = 18 |
|
---|---|---|
Subjects reporting at least one event∗ | 16 (45.7%) | 5 (27.8%) |
Subjects reporting at least one related event | 7 (20%) | 3 (16.7%) |
Subjects reporting at least one severe event | 0 | 0 |
Subjects reporting at least one event leading to study discontinuation | 6 (17.1%) | 1 (5.6%) |
∗ p = 0.206.